Qiming Venture Partners
About Qiming Venture Partners
Qiming Venture Partners is a premier Chinese venture capital firm known for backing early- to growth-stage tech and health-focused companies. The firm emphasizes entrepreneur-friendly partnerships and has a track record across technology, healthcare, and consumer markets, with a strong emphasis on supporting portfolio companies through strategic guidance and resources. Headquartered in China, it operates across domestic investments with international recognition for its performance and network.
Recent News
Oricell Therapeutics Secures $110 Million Pre‑IPO Funding, Spotlighting Investment Banking Activity
ShengShu Technology Raises Over RMB 600M in Series A+ Funding
Syneron Raises $150m for Macrocyclics, and Other Financings
Oricell Therapeutics Secures $110 Million to Take on One of Oncology's Most Vexing Problems
Vivatides Therapeutics Raises $54M for RNA Expansion
Oricell Closes a ‘Pre-IPO’ Megaround to Aim CAR-T at Solid Tumors
McKinsey Vet Franck Le Deu Joins Nisa Leung’s New Fund; Plus C-Suite Shuffle at Bicycle
Syneron Bio Raises $150M for Peptide Drug Platform
Genentech, SanegeneBio Launch Up-to-$1.7B RNAi Collaboration
Convergen Raises $10M in Seed Funding
